Literature DB >> 22972936

Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).

Jung-Soon Mo1, Fa-Xing Yu, Rui Gong, Joan Heller Brown, Kun-Liang Guan.   

Abstract

The Hippo signaling pathway plays a crucial role in tissue growth and tumorigenesis. Core components of the Hippo pathway include the MST1/2 and Lats1/2 kinases. Acting downstream from the Hippo pathway are the YAP/TAZ transcription coactivators, which are inhibited through phosphorylation by Lats. However, upstream signals that regulate the Hippo pathway have not been well delineated. Here we report that stimulation of protease-activated receptors (PARs) activates YAP/TAZ by decreasing phosphorylation and increasing nuclear localization. PAR1 acts through G(12/13) and Rho GTPase to inhibit the Lats1/2 kinase. Our observations establish thrombin as a physiological signal for the Hippo pathway and implicate Hippo-YAP as a key downstream signaling branch of PAR activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972936      PMCID: PMC3465735          DOI: 10.1101/gad.197582.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

Review 1.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway.

Authors:  Usha R Pendurthi; Mylinh Ngyuen; Patricia Andrade-Gordon; Lars C Petersen; L Vijaya Mohan Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

3.  Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.

Authors:  Joseph N McLaughlin; Lixin Shen; Michael Holinstat; Joshua D Brooks; Emmanuele Dibenedetto; Heidi E Hamm
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

4.  Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function.

Authors:  V Vouret-Craviari; P Boquet; J Pouysségur; E Van Obberghen-Schilling
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

5.  Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells.

Authors:  S Offermanns; S V Jones; E Bombien; G Schultz
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

6.  Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1.

Authors:  R C Chambers; P Leoni; O P Blanc-Brude; D E Wembridge; G J Laurent
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

7.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.

Authors:  Eunice H Y Chan; Marjaana Nousiainen; Ravindra B Chalamalasetty; Anja Schäfer; Erich A Nigg; Herman H W Silljé
Journal:  Oncogene       Date:  2005-03-17       Impact factor: 9.867

8.  Thrombin receptor overexpression in malignant and physiological invasion processes.

Authors:  S Even-Ram; B Uziely; P Cohen; S Grisaru-Granovsky; M Maoz; Y Ginzburg; R Reich; I Vlodavsky; R Bar-Shavit
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

Review 9.  Role and regulation of the thrombin receptor (PAR-1) in human melanoma.

Authors:  Carmen Tellez; Menashe Bar-Eli
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

10.  Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.

Authors:  Michelle A Booden; Lynn B Eckert; Channing J Der; JoAnn Trejo
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

View more
  143 in total

1.  Alternative Wnt Signaling Activates YAP/TAZ.

Authors:  Hyun Woo Park; Young Chul Kim; Bo Yu; Toshiro Moroishi; Jung-Soon Mo; Steven W Plouffe; Zhipeng Meng; Kimberly C Lin; Fa-Xing Yu; Caroline M Alexander; Cun-Yu Wang; Kun-Liang Guan
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

Review 2.  Drug development against the hippo pathway in mesothelioma.

Authors:  Gavitt A Woodard; Yi-Lin Yang; Liang You; David M Jablons
Journal:  Transl Lung Cancer Res       Date:  2017-06

3.  Defining the protein-protein interaction network of the human hippo pathway.

Authors:  Wenqi Wang; Xu Li; Jun Huang; Lin Feng; Keithlee G Dolinta; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

4.  Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.

Authors:  Xiaoming Dai; Peilu She; Fangtao Chi; Ying Feng; Huan Liu; Daqing Jin; Yiqiang Zhao; Xiaocan Guo; Dandan Jiang; Kun-Liang Guan; Tao P Zhong; Bin Zhao
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

5.  JCAD, a Gene at the 10p11 Coronary Artery Disease Locus, Regulates Hippo Signaling in Endothelial Cells.

Authors:  Peter D Jones; Michael A Kaiser; Maryam Ghaderi Najafabadi; Simon Koplev; Yuqi Zhao; Gillian Douglas; Theodosios Kyriakou; Sarah Andrews; Rathinasabapathy Rajmohan; Hugh Watkins; Keith M Channon; Shu Ye; Xia Yang; Johan L M Björkegren; Nilesh J Samani; Tom R Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 6.  Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.

Authors:  J Wang; J F Martin
Journal:  J Dent Res       Date:  2017-07-12       Impact factor: 6.116

7.  AMOT130 linking F-actin to YAP is involved in intervertebral disc degeneration.

Authors:  Cong Zhang; Feng Wang; Zhiyang Xie; Lu Chen; Arjun Sinkemani; Haomin Yu; Xiaotao Wu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

8.  Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells.

Authors:  Weicheng Zhang; Jingyuan Shen; Fengming Gu; Ying Zhang; Wenjuan Wu; Jiachun Weng; Yuexia Liao; Zijing Deng; Qing Yuan; Lu Zheng; Yu Zhang; Weigan Shen
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

9.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

10.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.